Silence Therapeutics's total assets for Q4 2025 were £97.55M, a decrease of -33.54% from the previous quarter. SLN total liabilities were £51.31M for the fiscal quarter, a -29.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.